Abstract:Cocrystallization of racemic-compound-forming chiral molecules can result in conglomerate cocrystals or diastereomerically related cocrystals, which enable the application of chiral separation techniques such as preferential crystallization and classic resolution. Here, a systematic method to identify the types and phase diagrams of cocrystals formed by chiral target compounds and candidate coformers in a particular solvent system is presented, which allows the design of suitable chiral resolution processes. The method is based on saturation temperature measurements of specific solution compositions containing both enantiomers of chiral molecules and a coformer. This method is applied to analyze three different systems. For racemic phenylalanine (Phe) in water/ethanol mixtures one of the enantiomers selectively cocrystallizes with the opposite enantiomer of valine (Val), forming the more stable diastereomerically related cocrystal. The racemic compound ibuprofen crystallizes with the nonchiral coformer 1,2-bis(4-pyridyl)ethane (BPN) as racemic compound cocrystals. More interestingly, when it is combined with <i>trans</i>-1-(2-pyridyl)-2-(4-pyridyl)ethylene (BPE), the racemic compound ibuprofen cocrystallizes as a conglomerate, which in principle enables the application of preferential crystallization of this racemic compound. The systematic method shows the benefit of using pseudo-binary phase diagrams. Such pseudo-binary phase diagrams depict the saturation temperature on a very specific route through the quaternary phase diagram, allowing the identification of various cocrystal types as well as the corresponding cocrystallization conditions. The systematic method can be used to identify a suitable solid phase for chiral separation, and the obtained phase diagram information enables the performance of a crystallization-mediated chiral resolution process design. Such a guideline for a chiral resolution process design has never been reported for conglomerate cocrystal systems such as IBU:BPE, presented in this study.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.cgd.0c00890?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.cgd.0c00890</a>.XRPD diffractograms of all relevant crystalline products from the present study (<a class="ext-link" href="/doi/suppl/10.1021/acs.cgd.0c00890/suppl_file/cg0c00890_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for Praziquantel

How Many Cocrystals Are We Missing? Assessing Two Crystal Engineering Approaches to Pharmaceutical Cocrystal Screening

Efficient Screening of Coformers for Active Pharmaceutical Ingredient Cocrystallization

Mechanochemical Synthesis of New Praziquantel Cocrystals: Solid-State Characterization and Solubility

Feasibility of thermal methods on screening, characterization and physicochemical evaluation of pharmaceutical cocrystals

Evaluating experimental, knowledge-based and computational cocrystal screening methods to advance drug-drug cocrystal fixed-dose combination development

A Review to Find Efficient, Cost-Effective, and User-Friendly Approaches

Evaluation on Cocrystal Screening Methods and Synthesis of Multicomponent Crystals: A Case Study

Computational screening for prediction of co-crystals: method comparison and experimental validation

Efficient cocrystal coformer screening based on a Machine learning Strategy: A case study for the preparation of imatinib cocrystal with enhanced physicochemical properties

Screening Approach for Identifying Cocrystal Types and Resolution Opportunities in Complex Chiral Multicomponent Systems

Virtual Screening, Structural Analysis, and Formation Thermodynamics of Carbamazepine Cocrystals

A preformulation co-crystal screening case study: Polymorphic co-crystals of an imidazopyridazine antimalarial drug lead with the coformer succinic acid

High-Throughput Encapsulated Nanodroplet Screening for Accelerated Co-Crystal Discovery

Combining a Drug and a Nutraceutical: A New Cocrystal of Praziquantel and Curcumin

Polymorphs of praziquantel–succinic acid cocrystal: Crystal structure, thermodynamic relationship, and improved pharmaceutical performance

Conformation, Virtual Cocrystal Screening, Synthesis and Determination of Dipyridamole

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Cocrystals of Praziquantel with Phenolic Acids: Discovery, Characterization, and Evaluation

Two Novel CL-20 Cocrystals with Different Performances Obtained by Molecular Similarity Combined with Hydrogen Bonding Pairing Energy: An Effective Strategy to Design and Screen Energetic Cocrystals

Cocrystal screening of benznidazole based on electronic transition, molecular reactivity, hydrogen bonding, and stability